http://rdf.ncbi.nlm.nih.gov/pubchem/patent/CN-106008502-B
Outgoing Links
Predicate | Object |
---|---|
classificationCPCInventive | http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C07D225-04 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C07C251-20 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C07C249-02 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C07D471-08 |
classificationIPCInventive | http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61P35-00 http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/C07D471-08 http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61P29-00 http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/C07C251-20 http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/C07D225-04 http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/C07C249-02 |
filingDate | 2016-06-06-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
grantDate | 2017-09-26-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
publicationDate | 2017-09-26-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
publicationNumber | CN-106008502-B |
titleOfInvention | Purslane middle skeleton alkaloid compound and its extraction separation method |
abstract | The present invention relates to traditional Chinese medicine extraction, separation field, more particularly to extracting and developing and the new skeleton alkaloids compound identified and its extraction separation method from purslane.Described new skeleton alkaloids compound, formula is C to molecule successively 18 H 26 N 2 O, C 18 H 24 N 2 O 2 , C 18 H 28 N 2 O 2 , it is named as Oleracimine, Oleracimine A and Oleracone A.The extraction separation method of above-mentioned noval chemical compound is also provided, successively using compression leg and Sephadex LH 20 in water boiling and extraction, ethyl acetate extraction, silica gel column chromatography, ODS, successfully extract and isolate the unique new alkaloids compound of skeleton, noval chemical compound has anti-inflammatory, analgesia and antitumor action, noval chemical compound and its salt or derivative of the present invention can be used as other compound synthesis primers, and the raw material of new drug development and pharmacology activity research, for preparing anti-inflammatory, treatment pain and anti-tumor drug or health products. |
priorityDate | 2016-06-06-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
type | http://data.epo.org/linked-data/def/patent/Publication |
Incoming Links
Total number of triples: 98.